Additonal
Resources
This page offers a collection of educational resources related to psilocybin and psychedelic-assisted therapy, beyond academic publications. Here you’ll find accessible articles, multimedia content, and external links that may help deepen your understanding of this emerging field. These materials are intended to support patients, caregivers, and healthcare professionals.
Centre for Psychedelics Health & Research
.png)
Centre for Psychedelics Health Research (CPHR) is a Canadian research and education hub dedicated to advancing rigorous, ethical, and evidence-based psychedelic science. CPHR supports clinical trials, knowledge translation, and public education focused on mental health and serious illness, while fostering interdisciplinary collaboration across healthcare, academia, and policy.
Through its partnership with CAN-PACT, CPHR contributes scientific expertise, educational resources, and research leadership to help advance psychedelic-assisted therapy in oncology and palliative care settings. Together, we are working to build responsible clinical pathways, support training and implementation, and expand access to high-quality information for clinicians, researchers, and patients.
CPHR also produces The Integration Session, a podcast featuring conversations with researchers, clinicians, and leaders in psychedelic science. The series explores emerging evidence, clinical applications, ethical considerations, and the evolving role of psychedelic-assisted therapies in mental health and serious illness care.
1
Inside CAN-PACT: Transforming Cancer Care with Psychedelics - The Integration Session
Key points in this Podcast:
-
Canadian researchers have secured $5M to advance psychedelic-assisted cancer care, signaling major momentum in the field.
-
In this episode, Dr. Ron Shore and Dr. Harriet Richardson share an inside look at CAN-PACT, a national network driving research, clinician training, and policy development in psychedelic oncology.
-
The conversation explores how psychedelics may help people with cancer, including relief of anxiety, depression, and existential distress.
-
They outline CAN-PACT’s 5–10 year research roadmap, including clinical trials, multi-site studies, and training initiatives.
-
The episode also discusses when psychedelic therapy may realistically become accessible to patients in Canada.
-
Featuring experts with decades of experience in cancer research, mental health, and psychedelic science, the episode offers a balanced, evidence-based, and hopeful vision for the future of cancer care.
2
The Magic Behind the Molecules: Psilocybin vs. Alcohol
Key points in this Article:
-
People often assume psychedelics are more dangerous than alcohol because psychedelics are illegal.
-
Alcohol and psilocybin have different effects on the brain and produce different experiences.
-
Psilocybin is generally considered non-addictive and has a low risk of overdose.
5
The Cultural Importance of Setting in Psychedelic Therapy
Key points in this article:
-
Mindset & Environment Matter: Both an individual’s mindset (“set”) and the therapy environment (“setting”) are shaped by culture and strongly influence psychedelic therapy outcomes.
-
Therapeutic Space: Room design, decor, and symbols can either promote safety and belonging or trigger exclusion and distress.
-
Music Isn’t Neutral: All music carries cultural meaning; playlists should reflect participants’ backgrounds and preferences.
-
Therapist Diversity & Sensitivity: A diverse, culturally aware therapy team fosters greater trust and inclusion.
-
Need for Adaptation: More research and innovation are needed to ensure psychedelic therapy is accessible, relevant, and effective across cultures.
6
Happy Enough: Can psychedelics improve your mental health?
Psychedelics, substances like LSD and psilocybin mushrooms that cause altered states of consciousness, often remind people of hippies in the 1960s. But more researchers are looking into their potential benefits for our well-being. Scientists say psychedelics – which are illegal for recreational use in Canada – could have massive implications on how we treat and heal from major mental health disorders like PTSD, depression and anxiety. Garvia speaks with Dr. Monnica Williams, clinical psychologist and professor at the University of Ottawa, where she is the co-director of the new master’s program in psychedelics and consciousness studies. They discuss the latest research and whether psychedelics will, and should, become mainstream.